UCB's Zogenix Bet Pays Out Quickly With Fresh Fintepla Approval

Second Indication For Rare Epilepsy Potential Blockbuster

 
• By Kevin Grogan
  
Van Zyl, Charl
Charl van Zyl

More from New Products

More from Scrip